SMI Expanded
1.827,27
PKT
-21,84
PKT
-1,18
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 14.07.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.07.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 13.07.17 | Nestlé buy | UBS AG | |
| 13.07.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | Holcim Neutral | UBS AG | |
| 13.07.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.07.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 12.07.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 12.07.17 | UBS buy | Goldman Sachs Group Inc. | |
| 12.07.17 | Roche buy | Jefferies & Company Inc. | |
| 12.07.17 | Zurich Insurance overweight | Barclays Capital | |
| 11.07.17 | Roche Reduce | HSBC | |
| 11.07.17 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.07.17 | Roche overweight | Morgan Stanley | |
| 11.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.07.17 | Roche neutral | Kepler Cheuvreux | |
| 10.07.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 10.07.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 10.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 10.07.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 07.07.17 | UBS Sector Perform | RBC Capital Markets | |
| 07.07.17 | UBS buy | Kepler Cheuvreux | |
| 07.07.17 | Novartis Hold | Deutsche Bank AG | |
| 07.07.17 | Roche Hold | Deutsche Bank AG | |
| 06.07.17 | Holcim Outperform | Bernstein Research | |
| 06.07.17 | Roche Neutral | UBS AG | |
| 06.07.17 | Nestlé Outperform | RBC Capital Markets | |
| 05.07.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 05.07.17 | Holcim Hold | Deutsche Bank AG | |
| 05.07.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 05.07.17 | Roche buy | Citigroup Corp. | |
| 05.07.17 | Novartis Underperform | Credit Suisse Group | |
| 04.07.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 04.07.17 | Givaudan Hold | Deutsche Bank AG | |
| 04.07.17 | UBS overweight | Morgan Stanley | |
| 04.07.17 | Novartis buy | Kepler Cheuvreux | |
| 04.07.17 | Swiss Re buy | HSBC |